Anticoagulation and Pulmonary Fibrosis: Friends, Foes, or Functional Allies?

Chest. 2021 Apr;159(4):1321-1323. doi: 10.1016/j.chest.2021.01.061. Epub 2021 Apr 6.

Authors

Cathryn T Lee¹, Ayodeji Adegunsoye²

Affiliations

¹ Department of Medicine, Section of Pulmonary & Critical Care, The University of Chicago, Chicago, IL.
² Department of Medicine, Section of Pulmonary & Critical Care, The University of Chicago, Chicago, IL. Electronic address: deji@uchicago.edu.

PMID: 34021989
DOI: 10.1016/j.chest.2021.01.061

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Anticoagulants / adverse effects
Friends*
Health Services
Humans
Pulmonary Fibrosis*

Substances

Anticoagulants

Grants and funding

K23 HL146942/HL/NHLBI NIH HHS/United States